Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Charles Simonton , Craig Thompson , Jason R Wollmuth , et al Added: 3 years ago
Coronary artery disease (CAD) is a leading cause of morbidity and mortality globally, despite advances in medical and preventive therapy. It is estimated that 18.2 million adults in the US have CAD, with 720,000 Americans projected to have a first hospitalization for MI or CAD death this year.1 Treatment of patients with symptomatic CAD includes guideline-directed medical therapy and coronary… View more
Author(s): Ahmed M Alabbady , Ahmed S Abdul-Al , Kimberly A Skelding Added: 3 years ago
The introduction of percutaneous coronary angioplasty in 1977 by Dr Andreas Grüntzig1 was one of the most remarkable achievements in the cardiology realm, opening the door to numerous advancements in percutaneous coronary interventions (PCIs). Due to advances in PCI techniques over the past four decades, catheters along with four generations of coronary stents have dramatically changed the… View more
Author(s): Timothy M Markman , Daniel A McBride , Jackson J Liang Added: 3 years ago
Ventricular tachycardia (VT) occurs most frequently in patients with structural heart disease. Management of VT in these patients can be complex, requiring an integrated approach with multiple therapeutic modalities. Antiarrhythmic drugs (AADs) can be effective in the management of VT and implantable cardioverter defibrillators (ICDs) have been shown to effectively prevent sudden cardiac death… View more
Author(s): Nader Moazami Added: 3 years ago
Among the many advances in medical therapy, the last decade has certainly witnessed the emergence of mechanical assist therapy from a dream to a tangible reality. Advances in device design, surgical techniques, and post-operative management have clearly and firmly established these devices as a critical option available for the treatment a challenging group of patients with heart failure. This… View more
Author(s): James N Kirkpatrick , Susan E Wiegers , J Eduardo Rame , et al Added: 3 years ago
There are at least five million patients with heart failure (HF) in the US, 5% of whom are considered end-stage.1 Mechanical circulatory support (MCS) in the form of ventricular assist devices (VADs) is becoming an increasingly important option for these patients. Previously reserved for rescuing patients in the throes of refractory cardiogenic shock, MCS is now a mainstay of end-stage heart… View more